MacroGenics
MGNX
#8706
Rank
NZ$0.39 B
Marketcap
NZ$6.28
Share price
-2.38%
Change (1 day)
135.18%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): NZ-$2.62

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$2.60. In 2025 the company made an earnings per share (EPS) of NZ-$2.01 a decrease over its 2024 EPS that were of NZ-$1.82.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.6230.68%
2025NZ-$2.0110.28%
2024NZ-$1.82613.33%
2023NZ-$0.26-92.31%
2022NZ-$3.32-42.14%
2021NZ-$5.7336.44%
2020NZ-$4.20-21.84%
2019NZ-$5.38-24.58%
2018NZ-$7.13675.93%
2017NZ-$0.92-68.05%
2016NZ-$2.88168.25%
2015NZ-$1.07-55%
2014NZ-$2.383400%
2013NZ-$0.06806-108.68%
2012NZ$0.7824.49%
2011NZ$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.23-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.03-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.64-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.63-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.08-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.06-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.90 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA